79 related articles for article (PubMed ID: 15363360)
1. [Relation Between microsomal epoxide hydrolase polymorphism and susceptibility to ovarian epithelial cancer].
Kang S; Duan LH; Li Y; Song JF; Zhang JH
Zhonghua Fu Chan Ke Za Zhi; 2004 Aug; 39(8):556-7. PubMed ID: 15363360
[No Abstract] [Full Text] [Related]
2. Microsomal epoxide hydrolase polymorphism and susceptibility to ovarian cancer.
Baxter SW; Choong DY; Campbell IG
Cancer Lett; 2002 Mar; 177(1):75-81. PubMed ID: 11809533
[TBL] [Abstract][Full Text] [Related]
3. Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer.
Lancaster JM; Brownlee HA; Bell DA; Futreal PA; Marks JR; Berchuck A; Wiseman RW; Taylor JA
Mol Carcinog; 1996 Nov; 17(3):160-2. PubMed ID: 8944076
[TBL] [Abstract][Full Text] [Related]
4. An interleukin-6 gene promoter polymorphism influences the biological phenotype of ovarian cancer.
Hefler LA; Grimm C; Ackermann S; Malur S; Radjabi-Rahat AR; Leodolter S; Beckmann MW; Zeillinger R; Koelbl H; Tempfer CB
Cancer Res; 2003 Jun; 63(12):3066-8. PubMed ID: 12810629
[TBL] [Abstract][Full Text] [Related]
5. Lactase persistence and ovarian carcinoma risk in Finland, Poland and Sweden.
Kuokkanen M; Butzow R; Rasinperä H; Medrek K; Nilbert M; Malander S; Lubinski J; Järvelä I
Int J Cancer; 2005 Oct; 117(1):90-4. PubMed ID: 15880573
[TBL] [Abstract][Full Text] [Related]
6. The microsomal epoxide hydrolase Tyr113His polymorphism: association with risk of ovarian cancer.
Spurdle AB; Purdie DM; Webb PM; Chen X; Green A; Chenevix-Trench G
Mol Carcinog; 2001 Jan; 30(1):71-8. PubMed ID: 11255266
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer.
Zorn KK; Bonome T; Gangi L; Chandramouli GV; Awtrey CS; Gardner GJ; Barrett JC; Boyd J; Birrer MJ
Clin Cancer Res; 2005 Sep; 11(18):6422-30. PubMed ID: 16166416
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms of cytochrome P450 CYP1A1 (*2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from North India.
Srivastava DS; Mandhani A; Mittal RD
Arch Toxicol; 2008 Sep; 82(9):633-9. PubMed ID: 18200441
[TBL] [Abstract][Full Text] [Related]
9. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.
Marquez RT; Baggerly KA; Patterson AP; Liu J; Broaddus R; Frumovitz M; Atkinson EN; Smith DI; Hartmann L; Fishman D; Berchuck A; Whitaker R; Gershenson DM; Mills GB; Bast RC; Lu KH
Clin Cancer Res; 2005 Sep; 11(17):6116-26. PubMed ID: 16144910
[TBL] [Abstract][Full Text] [Related]
10. Differentially androgen-modulated genes in ovarian epithelial cells from BRCA mutation carriers and control patients predict ovarian cancer survival and disease progression.
Motamed-Khorasani A; Jurisica I; Letarte M; Shaw PA; Parkes RK; Zhang X; Evangelou A; Rosen B; Murphy KJ; Brown TJ
Oncogene; 2007 Jan; 26(2):198-214. PubMed ID: 16832351
[TBL] [Abstract][Full Text] [Related]
11. BRCA2 Arg372Hispolymorphism and epithelial ovarian cancer risk.
Auranen A; Spurdle AB; Chen X; Lipscombe J; Purdie DM; Hopper JL; Green A; Healey CS; Redman K; Dunning AM; Pharoah PD; Easton DF; Ponder BA; Chenevix-Trench G; Novik KL
Int J Cancer; 2003 Jan; 103(3):427-30. PubMed ID: 12471628
[TBL] [Abstract][Full Text] [Related]
12. Ovarian cancer is a heterogeneous disease.
Wang V; Li C; Lin M; Welch W; Bell D; Wong YF; Berkowitz R; Mok SC; Bandera CA
Cancer Genet Cytogenet; 2005 Sep; 161(2):170-3. PubMed ID: 16102589
[TBL] [Abstract][Full Text] [Related]
13. Combined analysis of polymorphisms in glutathione S-transferase M1 and microsomal epoxide hydrolase in lung cancer patients.
Habalová V; Salagovic J; Kalina I; Stubna J
Neoplasma; 2004; 51(5):352-7. PubMed ID: 15640939
[TBL] [Abstract][Full Text] [Related]
14. Opposite alterations of DNA methyltransferase gene expression in endometrioid and serous endometrial cancers.
Xiong Y; Dowdy SC; Xue A; Shujuan J; Eberhardt NL; Podratz KC; Jiang SW
Gynecol Oncol; 2005 Mar; 96(3):601-9. PubMed ID: 15721400
[TBL] [Abstract][Full Text] [Related]
15. P53 gene status in patients with advanced serous epithelial ovarian cancer in relation to response to paclitaxel- plus platinum-based chemotherapy and long-term clinical outcome.
Gadducci A; Di Cristofano C; Zavaglia M; Giusti L; Menicagli M; Cosio S; Naccarato AG; Genazzani AR; Bevilacqua G; Cavazzana AO
Anticancer Res; 2006; 26(1B):687-93. PubMed ID: 16739339
[TBL] [Abstract][Full Text] [Related]
16. The association between microsomal epoxide hydrolase genotypes and esophageal squamous-cell-carcinoma in Taiwan: interaction between areca chewing and smoking.
Lin YC; Wu DC; Lee JM; Hsu HK; Kao EL; Yang CH; Wu MT
Cancer Lett; 2006 Jun; 237(2):281-8. PubMed ID: 16029924
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms of microsomal epoxide hydrolase in French vinyl chloride workers.
Li Y; Lee S; Marion MJ; Brandt-Rauf PW
Int J Occup Med Environ Health; 2005; 18(2):133-8. PubMed ID: 16201204
[TBL] [Abstract][Full Text] [Related]
18. Microsomal epoxide hydrolase polymorphisms and risk for advanced colorectal adenoma.
Huang WY; Chatterjee N; Chanock S; Dean M; Yeager M; Schoen RE; Hou LF; Berndt SI; Yadavalli S; Johnson CC; Hayes RB
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):152-7. PubMed ID: 15668489
[TBL] [Abstract][Full Text] [Related]
19. Association of microsomal epoxide hydrolase gene polymorphism and pre-eclampsia in Turkish women.
Pinarbasi E; Percin FE; Yilmaz M; Akgun E; Cetin M; Cetin A
J Obstet Gynaecol Res; 2007 Feb; 33(1):32-7. PubMed ID: 17212663
[TBL] [Abstract][Full Text] [Related]
20. Her-2/neu expression and amplification in early stage ovarian surface epithelial neoplasms.
Wu Y; Soslow RA; Marshall DS; Leitao M; Chen B
Gynecol Oncol; 2004 Dec; 95(3):570-5. PubMed ID: 15581965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
